CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06080581
NCT06080581N/ACompleted

Mitochondrial Derangements Driving Muscle Insulin Resistance in Humans

Rigshospitalet, Denmark·observational·Posted Oct 12, 2023·Updated Jun 22, 2025

In Brief

An observational study for Mitochondrial Myopathies and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The overarching aim of this observational study is to characterize muscle mitochondrial defects in individuals harboring pathogenic mitochondrial DNA (mtDNA) mutations associated with an insulin-resistant phenotype. In a case-control design, individuals with pathogenic mtDNA mutations will be compared to controls matched for sex, age, and physical activity level. Participants will attend a screening visit and two experimental trials including: * An oral glucose tolerance test * A hyperinsulinemic-euglycemic clamp combined with measurements of femoral artery blood flow and arteriovenous difference of glucose * Muscle biopsy samples

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/ACompletedFinished
202420252026
First PostedOct 12, 2023
Enrollment StartOct 20, 2023
Primary CompletionDec 20, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.7 years ago